Glob Bioenergi (France) Performance
| ALGBE Stock | EUR 0.81 0.02 2.41% |
The company retains a Market Volatility (i.e., Beta) of -2.25, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Glob Bioenergi are expected to decrease by larger amounts. On the other hand, during market turmoil, Glob Bioenergi is expected to outperform it. At this point, Glob Bioenergi has a negative expected return of -0.45%. Please make sure to check out Glob Bioenergi's treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if Glob Bioenergi performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Glob Bioenergi has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 14.2 M | |
| Total Cashflows From Investing Activities | -2.5 M |
Glob |
Glob Bioenergi Relative Risk vs. Return Landscape
If you would invest 172.00 in Glob Bioenergi on August 30, 2024 and sell it today you would lose (91.00) from holding Glob Bioenergi or give up 52.91% of portfolio value over 90 days. Glob Bioenergi is generating negative expected returns and assumes 12.5515% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Glob on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Glob Bioenergi Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Glob Bioenergi's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Glob Bioenergi, and traders can use it to determine the average amount a Glob Bioenergi's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0361
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALGBE |
Estimated Market Risk
| 12.55 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Glob Bioenergi is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Glob Bioenergi by adding Glob Bioenergi to a well-diversified portfolio.
Glob Bioenergi Fundamentals Growth
Glob Stock prices reflect investors' perceptions of the future prospects and financial health of Glob Bioenergi, and Glob Bioenergi fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Glob Stock performance.
| Return On Equity | -1.13 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (7.69) % | |||
| Current Valuation | 51.76 M | |||
| Shares Outstanding | 14.85 M | |||
| Price To Earning | (5.10) X | |||
| Price To Book | 4.37 X | |||
| Price To Sales | 60.53 X | |||
| Revenue | 100.94 K | |||
| EBITDA | (12.13 M) | |||
| Cash And Equivalents | 146.65 K | |||
| Cash Per Share | 2.12 X | |||
| Total Debt | 5.13 M | |||
| Debt To Equity | 145.30 % | |||
| Book Value Per Share | 0.88 X | |||
| Cash Flow From Operations | (11.88 M) | |||
| Earnings Per Share | (0.48) X | |||
| Total Asset | 31.79 M | |||
| Retained Earnings | (28 M) | |||
| Current Asset | 13 M | |||
| Current Liabilities | 2 M | |||
About Glob Bioenergi Performance
Assessing Glob Bioenergi's fundamental ratios provides investors with valuable insights into Glob Bioenergi's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Glob Bioenergi is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Global Bioenergies SA focuses on the development of a biological process for converting renewable resources into isobutene. Global Bioenergies SA was founded in 2008 and is headquartered in Evry, France. GLOBAL BIOENERGIES operates under Utilities - Diversified classification in France and is traded on Paris Stock Exchange. It employs 54 people.Things to note about Glob Bioenergi performance evaluation
Checking the ongoing alerts about Glob Bioenergi for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Glob Bioenergi help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Glob Bioenergi generated a negative expected return over the last 90 days | |
| Glob Bioenergi has high historical volatility and very poor performance | |
| Glob Bioenergi has some characteristics of a very speculative penny stock | |
| Glob Bioenergi has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 100.94 K. Net Loss for the year was (11.77 M) with loss before overhead, payroll, taxes, and interest of (5.32 M). | |
| Glob Bioenergi has accumulated about 146.65 K in cash with (11.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 16.0% of the company shares are held by company insiders |
- Analyzing Glob Bioenergi's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Glob Bioenergi's stock is overvalued or undervalued compared to its peers.
- Examining Glob Bioenergi's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Glob Bioenergi's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Glob Bioenergi's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Glob Bioenergi's stock. These opinions can provide insight into Glob Bioenergi's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Glob Stock Analysis
When running Glob Bioenergi's price analysis, check to measure Glob Bioenergi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glob Bioenergi is operating at the current time. Most of Glob Bioenergi's value examination focuses on studying past and present price action to predict the probability of Glob Bioenergi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glob Bioenergi's price. Additionally, you may evaluate how the addition of Glob Bioenergi to your portfolios can decrease your overall portfolio volatility.